Benatpharma SRL
0.7 FTEThe score of Benatpharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -19 % Total assets -12 % Headcount (avg FTE) +40 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Benatpharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 38,913 € | ||||
| Equity | 101,151 € | ||||
| Cash | 66,802 € | ||||
| EBITDA | 90,089 € | ||||
| Total assets | 420,772 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Aug 2026
- Year ended 31 Dec 2024filed on 20 Aug 2025
- Year ended 31 Dec 2023filed on 22 Jul 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
Benatpharma's financial analysis
- Solvency24.0%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Benatpharma
Benatpharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0818.169.561
- VAT number
- BE0818169561
- Peppol
- Registered · 0208:0818169561 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 01 Sep 2009
- Registered office
- 1090 Jette
- Size
- Micro · 0.7 FTE
- Latest accounts
- 2025 · filed on 28 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Benatpharma (SRL) has been based in Jette since 2009, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 38,913 € and equity of 101,151 €; its revenue is not published. With 0.7 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 24.0%, below the median of its sector (37.8%).
Companies similar to Benatpharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek VAN Reeth Retail sale of pharmaceutical products Antwerp · balance sheet 420,608 €
- Pharmacie Botanique Retail sale of pharmaceutical products Brussels · balance sheet 421,353 €
- B.K. Pharma Retail sale of pharmaceutical products Anderlecht · balance sheet 421,476 €
- Hestia Retail sale of pharmaceutical products Ghent · balance sheet 419,536 €
- Budin-Conserva Retail sale of pharmaceutical products Roeselare · balance sheet 419,437 €
- Frenaver Retail sale of pharmaceutical products Heist-op-den-Berg · balance sheet 418,862 €
- Coriphar Retail sale of pharmaceutical products Tienen · balance sheet 425,689 €
- Apotheke Bocken Retail sale of pharmaceutical products Eupen · balance sheet 426,403 €
Frequently asked questions about Benatpharma
What is the revenue of Benatpharma?
Benatpharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Benatpharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0818169561 for Benatpharma, if the company is VAT-registered. Its company number (CBE) is 0818.169.561.
Where is the registered office of Benatpharma?
According to the CBE register, the registered office of Benatpharma is in 1090 Jette.
What is the equity of Benatpharma?
At the close of the 2025 financial year, the equity of Benatpharma amounts to 101,151 €, a solvency of 24.0% of total assets.
How many people work at Benatpharma?
0.7 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Benatpharma?
The register lists 2 active mandates at Benatpharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Benatpharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →